The phytoestrogen genistein affects zebrafish development through two different pathways

PLoS ONE

Volumn 4, Issue 3, 2009, Pages

  Sassi Messai, Sana ^a   Gibert, Yann ^a   Bernard, Laure ^a   Nishio, Shin Ichi ^a   Ferri Lagneau, Karine F ^b   Molina, José ^d   Andersson Lendahl, Monika ^c   Benoit, Gérard ^a   Balaguer, Patrick ^d   Laudet, Vincent ^a  

^a UNIVERSITÉ LYON 1   (France)

^b UNIVERSITÉ DE LYON   (France)

^c KAROLINSKA INSTITUTE   (Sweden)

^d INSERM   (France)

Author keywords

[No Author keywords available]

Indexed keywords

AROMATASE; AROMATASE B; ESTRADIOL; ESTROGEN RECEPTOR ALPHA; ESTROGEN RECEPTOR BETA; ESTROGEN RECEPTOR BETA A; ESTROGEN RECEPTOR BETA B; FULVESTRANT; GENISTEIN; UNCLASSIFIED DRUG; ESTROGEN RECEPTOR; PHYTOESTROGEN;

ANIMAL CELL; APOPTOSIS; ARTICLE; CONTROLLED STUDY; EMBRYO; EMBRYO DEVELOPMENT; ENZYME REGULATION; GENE EXPRESSION REGULATION; HORMONE ACTION; HORMONE RECEPTOR INTERACTION; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; LARVAL STAGE; MALE; NEUROTOXICITY; NONHUMAN; PHYTOTOXICITY; RHOMBENCEPHALON; SPINAL CORD; ZEBRA FISH; ANIMAL; BINDING SITE; CYTOLOGY; DRUG EFFECT; GENETICS; GROWTH, DEVELOPMENT AND AGING; LARVA; METABOLISM; TRANSCRIPTION INITIATION;

DANIO RERIO;

ANIMALS; APOPTOSIS; AROMATASE; BINDING SITES; GENISTEIN; GROWTH AND DEVELOPMENT; LARVA; PHYTOESTROGENS; RECEPTORS, ESTROGEN; RHOMBENCEPHALON; SPINAL CORD; TRANSCRIPTIONAL ACTIVATION; ZEBRAFISH;

EID: 63449083422     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0004935     Document Type: Article

References (71)

1. Crews D, McLachlan JA (2006) Epigenetics, evolution, endocrine disruption, health, and disease. Endocrinology 147: S4-10.
2. McLachlan JA (2001) Environmental signaling: what embryos and evolution teach us about endocrine disrupting chemicals. Endocr Rev 22: 319-341.
3. Waring RH, Harris RM (2005) Endocrine disrupters: a human risk? Mol Cell Endocrinol 244: 2-9.
4. Aggarwal BB, Shishodia S (2006) Molecular targets of dietary agents for prevention and therapy of cancer. Biochem Pharmacol 71: 1397-1421.
5. Henley DV, Korach KS (2006) Endocrine-disrupting chemicals use distinct mechanisms of action to modulate endocrine system function. Endocrinology 147: S25-32.
6. Strauss L, Santti R, Saarinen N, Streng T, Joshi S, et al. (1998) Dietary phytoestrogens and their role in hormonally dependent disease. Toxicol Lett 102-103: 349-354.
7. Fukutake M, Takahashi M, Ishida K, Kawamura H, Sugimura T, et al. (1996) Quantification of genistein and genistin in soybeans and soybean products. Food Chem Toxicol 34: 457-461.
8. Polkowski K, Mazurek AP (2000) Biological properties of genistein. A review of in vitro and in vivo data. Acta Pol Pharm 57: 135-155.
9. Sarkar FH, Li Y (2002) Mechanisms of cancer chemoprevention by soy isoflavone genistein. Cancer Metastasis Rev 21: 265-280.
10. Potter SM, Baum JA, Teng H, Stillman RJ, Shay NF, et al. (1998) Soy protein and isoflavones: their effects on blood lipids and bone density in postmenopausal women. Am J Clin Nutr 68: 1375S-1379S.
11. Cai Q, Wei H (1996) Effect of dietary genistein on antioxidant enzyme activities in SENCAR mice. Nutr Cancer 25: 1-7.
12. Zava DT, Duwe G (1997) Estrogenic and antiproliferative properties of genistein and other flavonoids in human breast cancer cells in vitro. Nutr Cancer 27: 31-40.
13. Kuiper GG, Lemmen JG, Carlsson B, Corton JC, Safe SH, et al. (1998) Interaction of estrogenic chemicals and phytoestrogens with estrogen receptor beta. Endocrinology 139: 4252-4263.
14. Makela S, Davis VL, Tally WC, Korkman J, Salo L, et al. (1994) Dietary Estrogens Act through Estrogen Receptor-Mediated Processes and Show No Antiestrogenicity in Cultured Breast Cancer Cells. Environ Health Perspect 102: 572-578.
15. Makela S, Poutanen M, Lehtimaki J, Kostian ML, Santti R, et al. (1995) Estrogen-specific 17 beta-hydroxysteroid oxidoreductase type 1 (E.C. 1.1.1.62) as a possible target for the action of phytoestrogens. Proc Soc Exp Biol Med 208: 51-59.
16. Dahlman-Wright K, Cavailles V, Fuqua SA, Jordan VC, Katzenellenbogen JA, et al. (2006) International Union of Pharmacology. LXIV. Estrogen receptors. Pharmacol Rev 58: 773-781.
17. Imamov O, Morani A, Shim GJ, Omoto Y, Thulin-Andersson C, et al. (2004) Estrogen receptor beta regulates epithelial cellular differentiation in the mouse ventral prostate. Proc Natl Acad Sci U S A 101: 9375-9380.
18. Barkhem T, Carlsson B, Nilsson Y, Enmark E, Gustafsson J, et al. (1998) Differential response of estrogen receptor alpha and estrogen receptor beta to partial estrogen agonists/antagonists. Mol Pharmacol 54: 105-112.
19. Hsieh RW, Rajan SS, Sharma SK, Guo Y, DeSombre ER, et al. (2006) Identification of ligands with bicyclic scaffolds provides insights into mechanisms of estrogen receptor subtype selectivity. J Biol Chem 281: 17909-17919.
20. An J, Tzagarakis-Foster C, Scharschmidt TC, Lomri N, Leitman DC (2001) Estrogen receptor beta-selective transcriptional activity and recruitment of coregulators by phytoestrogens. J Biol Chem 276: 17808-17814.
21. Patisaul HB (2005) Phytoestrogen action in the adult and developing brain. J Neuroendocrinol 17: 57-64.
22. Gronemeyer H, Gustafsson JA, Laudet V (2004) Principles for modulation of the nuclear receptor superfamily. Nat Rev Drug Discov 3: 950-964.
23. Manas ES, Xu ZB, Unwalla RJ, Somers WS (2004) Understanding the selectivity of genistein for human estrogen receptor-beta using X-ray crystallography and computational methods. Structure 12: 2197-2207.
24. Pike AC, Brzozowski AM, Hubbard RE, Bonn T, Thorsell AG, et al. (1999) Structure of the ligand-binding domain of oestrogen receptor beta in the presence of a partial agonist and a full antagonist. Embo J 18: 4608-4618.
25. Setchell KD (1998) Phytoestrogens: the biochemistry, physiology, and implications for human health of soy isoflavones. Am J Clin Nutr 68: 1333S-1346S.
26. Green NS, Foss TR, Kelly JW (2005) Genistein, a natural product from soy, is a potent inhibitor of transthyretin amyloidosis. Proc Natl Acad Sci U S A 102: 14545-14550.
27. Akiyama T, Ishida J, Nakagawa S, Ogawara H, Watanabe S, et al. (1987) Genistein, a specific inhibitor of tyrosine-specific protein kinases. J Biol Chem 262: 5592-5595.
28. Burvall K, Palmberg L, Larsson K (2004) Influence of 8-bromo-cyclicAMP on interleukin -6 and -8 mRNA levels in A549 human lung epithelial cells exposed to organic dust: a time-kinetic study. Life Sci 75: 2733-2749.
29. Hill AJ, Teraoka H, Heideman W, Peterson RE (2005) Zebrafish as a model vertebrate for investigating chemical toxicity. Toxicol Sci 86: 6-19.
30. Kime DE (1999) A strategy for assessing the effects of xenobiotics on fish reproduction. Sci Total Environ 225: 3-11.
31. Young WF, Whitehouse P, Johnson I, Sorokin N (2004) Proposed Predicted-No-Effect-Concentrations (PNECs) for Natural and Synthetic Steroid Oestrogens in Surface Waters. In: Environment Agency R&D Dissemination Centre coW, Frankland Road, Swindon, editor.
32. Jobling S, Nolan M, Tyler CR, Brighty G, Sumpter JP (1998) Widespread Sexual Disruption in Wild Fish. Environ Sci Technol 32: 2498-2506.
33. Gross-Sorokin MY, Roast SD, Brighty GC (2006) Assessment of feminization of male fish in English rivers by the Environment Agency of England and Wales. Environ Health Perspect 114 Suppl 1: 147-151.
34. Kiparissis Y, Hughes R, Metcalfe C, Ternes T (2001) Identification of the isoflavonoid genistein in bleached kraft mill effluent. Environ-Sci-Technol 35: 2423-2427.
35. Pelissero C, Bennetau B, Babin P, Le Menn F, Dunogues J (1991) The estrogenic activity of certain phytoestrogens in the Siberian sturgeon Acipenser baeri. J Steroid Biochem Mol Biol 38: 293-299.
36. Zhang L, Khan IA, Foran CM (2002) Characterization of the estrogenic response to genistein in Japanese medaka (Oryzias latipes). Comp Biochem Physiol C Toxicol Pharmacol 132: 203-211.
37. Kiparissis Y, Balch GC, Metcalfe TL, Metcalfe CD (2003) Effects of the isoflavones genistein and equol on the gonadal development of Japanese medaka Oryzias latipes. Environ Health Perspect 111: 1158-1163.
38. Bennetau-Pelissero C, Breton BB, Bennetau B, Corraze G, Le Menn F, et al. (2001) Effect of genistein-enriched diets on the endocrine process of gametogenesis and on reproduction efficiency of the rainbow trout Oncorhynchus mykiss. Gen Comp Endocrinol 121: 173-187.
39. Detrich HW 3rd, Westerfield M, Zon LI (1999) Overview of the Zebrafish system. Methods Cell Biol 59: 3-10.
40. Grunwald DJ, Eisen JS (2002) Headwaters of the zebrafish - emergence of a new model vertebrate. Nat Rev Genet 3: 717-724.
41. Lieschke GJ, Currie PD (2007) Animal models of human disease: zebrafish swim into view. Nat Rev Genet 8: 353-367.
42. Carvan MJ 3rd, Dalton TP, Stuart GW, Nebert DW (2000) Transgenic zebrafish as sentinels for aquatic pollution. Ann N Y Acad Sci 919: 133-147.
43. Eggert US, Mitchison TJ (2006) Small molecule screening by imaging. Curr Opin Chem Biol 10: 232-237.
44. Zon LI, Peterson RT (2005) In vivo drug discovery in the zebrafish. Nat Rev Drug Discov 4: 35-44.
45. Kimmel CB, Ballard WW, Kimmel SR, Ullmann B, Schilling TF (1995) Stages of embryonic development of the zebrafish. Dev Dyn 203: 253-310.
46. Chen H, Takahashi S, Imamura M, Okutani E, Zhang ZG, et al. (2007) Earthworm fibrinolytic enzyme: anti-tumor activity on human hepatoma cells in vitro and in vivo. Chin Med J (Engl) 120: 898-904.
47. Lawry J (2004) Detection of apoptosis by the TUNEL assay. Methods Mol Med 88: 183-190.
48. Bardet PL, Horard B, Robinson-Rechavi M, Laudet V, Vanacker JM (2002) Characterization of oestrogen receptors in zebrafish (Danio rerio). J Mol Endocrinol 28: 153-163.
49. Menuet A, Pellegrini E, Anglade I, Blaise O, Laudet V, et al. (2002) Molecular characterization of three estrogen receptor forms in zebrafish: binding characteristics, transactivation properties, and tissue distributions. Biol Reprod 66: 1881-1892.
50. Hall JM, Couse JF, Korach KS (2001) The multifaceted mechanisms of estradiol and estrogen receptor signaling. J Biol Chem 276: 36869-36872.
51. Ellis PA, Saccani-Jotti G, Clarke R, Johnston SR, Anderson E, et al. (1997) Induction of apoptosis by tamoxifen and ICI 182780 in primary breast cancer. Int J Cancer 72: 608-613.
52. Bertrand S, Thisse B, Tavares R, Sachs L, Chaumot A, et al. (2007) Unexpected novel relational links uncovered by extensive developmental profiling of nuclear receptor expression. PLoS Genet 3: e188.
53. Escriva H, Bertrand S, Germain P, Robinson-Rechavi M, Umbhauer M, et al. (2006) Neofunctionalization in vertebrates: the example of retinoic acid receptors. PLoS Genet 2: e102.
54. Escande A, Pillon A, Servant N, Cravedi JP, Larrea F, et al. (2006) Evaluation of ligand selectivity using reporter cell lines stably expressing estrogen receptor alpha or beta. Biochem Pharmacol 71: 1459-1469.
55. Legler J, Broekhof J, Brouwer A, Lanser PH, Murk A, et al. (2000) A novel in vivo bioassay for (Xeno-)estrogens using transgenic zebrafish. Environmental science&technolog 34: 4439-4444.
56. Legler J, Zeinstra LM, Schuitemaker F, Lanser PH, Bogerd J, et al. (2002) Comparison of in vivo and in vitro reporter gene assays for short-term screening of estrogenic activity. Environmental science&technology 36: 4410-4415.
57. Pellegrini E, Menuet A, Lethimonier C, Adrio F, Gueguen MM, et al. (2005) Relationships between aromatase and estrogen receptors in the brain of teleost fish. Gen Comp Endocrinol 142: 60-66.
58. Le Page Y, Scholze M, Kah O, Pakdel F (2006) Assessment of xenoestrogens using three distinct estrogen receptors and the zebrafish brain aromatase gene in a highly responsive glial cell system. Environ Health Perspect 114: 752-758.
59. Tchoudakova A, Kishida M, Wood E, Callard GV (2001) Promoter characteristics of two cyp19 genes differentially expressed in the brain and ovary of teleost fish. J Steroid Biochem Mol Biol 78: 427-439.
60. Kishida M, Callard GV (2001) Distinct cytochrome P450 aromatase isoforms in zebrafish (Danio rerio) brain and ovary are differentially programmed and estrogen regulated during early development. Endocrinology 142: 740-750.
61. Kazeto Y, Place AR, Trant JM (2004) Effects of endocrine disrupting chemicals on the expression of CYP19 genes in zebrafish (Danio rerio) juveniles. Aquat Toxicol 69: 25-34.
62. Menuet A, Pellegrini E, Brion F, Gueguen MM, Anglade I, et al. (2005) Expression and estrogen-dependent regulation of the zebrafish brain aromatase gene. J Comp Neurol 485: 304-320.
63. Panzica G, Mura E, Pessatti M, Viglietti-Panzica C (2005) Early embryonic administration of xenoestrogens alters vasotocin system and male sexual behavior of the Japanese quail. Domest Anim Endocrinol 29: 436-445.
64. Choi EJ, Lee BH (2004) Evidence for genistein mediated cytotoxicity and apoptosis in rat brain. Life Sci 75: 499-509.
65. Ismail IA, Kang KS, Lee HA, Kim JW, Sohn YK (2007) Genistein-induced neuronal apoptosis and G2/M cell cycle arrest is associated with MDC1 up-regulation and PLK1 down-regulation. Eur J Pharmacol 575: 12-20.
66. Chan WH, Lu HY, Shiao NH (2007) Effect of genistein on mouse blastocyst development in vitro. Acta Pharmacol Sin 28: 238-245.
67. Lewis JG, Nakajin S, Ohno S, Warnock A, Florkowski CM, et al. (2005) Circulating levels of isoflavones and markers of 5alpha-reductase activity are higher in Japanese compared with New Zealand males: what is the role of circulating steroids in prostate disease? Steroids 70: 974-979.
68. Valachovicova T, Slivova V, Sliva D (2004) Cellular and physiological effects of soy flavonoids. Mini Rev Med Chem 4: 881-887.
69. Kausch U, Alberti M, Haindl S, Budczies J, Hock B (2008) Biomarkers for exposure to estrogenic compounds: gene expression analysis in zebrafish (Danio rerio). Environ Toxicol 23: 15-24.
70. Thisse C, Thisse B, Schilling TF, Postlethwait JH (1993) Structure of the zebrafish snail1 gene and its expression in wild-type, spadetail and no tail mutant embryos. Development 119: 1203-1215.
71. Margueron R, Duong V, Bonnet S, Escande A, Vignon F, et al. (2004) Histone deacetylase inhibition and estrogen receptor alpha levels modulate the transcriptional activity of partial antiestrogens. J Mol Endocrinol 32: 583-594.